Vistin Pharma ASA: Second quarter and first half 2020 financial results
Vistin Pharma ASA announces the financial results for the second quarter and first half of 2020, with a 20% increase in revenue and EBITDA of MNOK 20.9 for the pharmaceutical business in Q2 – highest revenue and EBITDA ever in a quarter. For first half 2020 revenue increased by 30% and EBITDA by 200% versus first … Continue reading Vistin Pharma ASA: Second quarter and first half 2020 financial results Continue Reading

